KRSA
NASD Korsana Biosciences, Inc.$31.30 ↓ -0.35 (-1.11%) Trading Down from the previous close of $31.65, $1.10 below the day’s high of $32.40
- YTD change
- +19.47%
- vs 20-day SMA
- -1.57%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+5.57 (+21.26%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 16.0% away from all-time highs of $37.27
- KRSA is up 19% since the beginning of the year
- KRSA is up 19% over the past 12 months
- KRSA is up 19% over the past 1 month
- 0% of all KRSA investors are betting against KRSA
KRSA reads neutral: the 12-month move is +21.3%.
- Previous minute
- +$0.00
- Last hour
- -$0.35
- Last 5 days
- -7.94%
- vs 8-day SMA
- -0.64%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.